Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02184117 · ClinicalTrials.gov registry record
CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?)
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 763
- Enrollment target
NCT02184117 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 763 participants.
The verdict
NCT02184117 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 763 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the diagnostic performances of iodine contrast medium and resting conditions to predict fractional flow reserve (FFR). Reference FFR will be measured using standard adenosine. We hypothesize that contrast FFR will offer superior diagnostic agreement compared to resting conditions.
Interventions
- DRUG Adenosine
- DRUG Contrast Media
- DRUG Resting conditions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 763 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02184117
The ClinicalTrials.gov registry entry for NCT02184117 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 763 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Adenosine is the first listed.
NCT02184117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02184117 about?
NCT02184117 is a clinical study titled "CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?)". The purpose of this study is to determine the diagnostic performances of iodine contrast medium and resting conditions to predict fractional flow reserve (FFR). Reference FFR will be measured using standard adenosine. We hypothesize that contrast FFR will offer superior diagnostic agreement compared...
What is the current status of trial NCT02184117?
This trial is currently completed. The enrollment target is 763 participants. The study started on 2014-07. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02184117?
The interventions under investigation include: Adenosine (DRUG), Contrast Media (DRUG), Resting conditions (DRUG).
Who is sponsoring clinical trial NCT02184117?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.